271 related articles for article (PubMed ID: 31247877)
1. Copper-Targeting Approaches in Alzheimer's Disease: How To Improve the Fallouts Obtained from in Vitro Studies.
Esmieu C; Guettas D; Conte-Daban A; Sabater L; Faller P; Hureau C
Inorg Chem; 2019 Oct; 58(20):13509-13527. PubMed ID: 31247877
[TBL] [Abstract][Full Text] [Related]
2. Mutual interference of Cu and Zn ions in Alzheimer's disease: perspectives at the molecular level.
Atrián-Blasco E; Conte-Daban A; Hureau C
Dalton Trans; 2017 Oct; 46(38):12750-12759. PubMed ID: 28937157
[TBL] [Abstract][Full Text] [Related]
3. Why the Ala-His-His Peptide Is an Appropriate Scaffold to Remove and Redox Silence Copper Ions from the Alzheimer's-Related Aβ Peptide.
Gonzalez P; Sabater L; Mathieu E; Faller P; Hureau C
Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291536
[TBL] [Abstract][Full Text] [Related]
4. Regulatory Activities of Dopamine and Its Derivatives toward Metal-Free and Metal-Induced Amyloid-β Aggregation, Oxidative Stress, and Inflammation in Alzheimer's Disease.
Nam E; Derrick JS; Lee S; Kang J; Han J; Lee SJC; Chung SW; Lim MH
ACS Chem Neurosci; 2018 Nov; 9(11):2655-2666. PubMed ID: 29782798
[TBL] [Abstract][Full Text] [Related]
5. Copper and heme-mediated Abeta toxicity: redox chemistry, Abeta oxidations and anti-ROS compounds.
Chassaing S; Collin F; Dorlet P; Gout J; Hureau C; Faller P
Curr Top Med Chem; 2012; 12(22):2573-95. PubMed ID: 23339309
[TBL] [Abstract][Full Text] [Related]
6. How Zn can impede Cu detoxification by chelating agents in Alzheimer's disease: a proof-of-concept study.
Conte-Daban A; Day A; Faller P; Hureau C
Dalton Trans; 2016 Oct; 45(39):15671-15678. PubMed ID: 27711738
[TBL] [Abstract][Full Text] [Related]
7. Cu and Zn interactions with Aβ peptides: consequence of coordination on aggregation and formation of neurotoxic soluble Aβ oligomers.
Rana M; Sharma AK
Metallomics; 2019 Jan; 11(1):64-84. PubMed ID: 30234208
[TBL] [Abstract][Full Text] [Related]
8. Specific Binding of Cu(II) Ions to Amyloid-Beta Peptides Bound to Aggregation-Inhibiting Molecules or SDS Micelles Creates Complexes that Generate Radical Oxygen Species.
Tiiman A; Luo J; Wallin C; Olsson L; Lindgren J; Jarvet J; Per R; Sholts SB; Rahimipour S; Abrahams JP; Karlström AE; Gräslund A; Wärmländer SK
J Alzheimers Dis; 2016 Oct; 54(3):971-982. PubMed ID: 27567855
[TBL] [Abstract][Full Text] [Related]
9. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
Savelieff MG; DeToma AS; Derrick JS; Lim MH
Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
[TBL] [Abstract][Full Text] [Related]
10. Identifying, by first-principles simulations, Cu[amyloid-β] species making Fenton-type reactions in Alzheimer's disease.
La Penna G; Hureau C; Andreussi O; Faller P
J Phys Chem B; 2013 Dec; 117(51):16455-67. PubMed ID: 24313818
[TBL] [Abstract][Full Text] [Related]
11. Unexpected Trends in Copper Removal from Aβ Peptide: When Less Ligand Is Better and Zn Helps.
Esmieu C; Balderrama-Martínez-Sotomayor R; Conte-Daban A; Iranzo O; Hureau C
Inorg Chem; 2021 Jan; 60(2):1248-1256. PubMed ID: 33400522
[TBL] [Abstract][Full Text] [Related]
12. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
Drew SC; Barnham KJ
Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
[TBL] [Abstract][Full Text] [Related]
13. Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles.
Faller P; Hureau C; La Penna G
Acc Chem Res; 2014 Aug; 47(8):2252-9. PubMed ID: 24871565
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of human serum albumin on Cu-induced Aβ(40) aggregation and toxicity.
Lu N; Yang Q; Li J; Tian R; Peng YY
Eur J Pharmacol; 2015 Nov; 767():160-4. PubMed ID: 26463036
[TBL] [Abstract][Full Text] [Related]
15. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
Smith DG; Cappai R; Barnham KJ
Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
[TBL] [Abstract][Full Text] [Related]
16. Ability of Azathiacyclen Ligands To Stop Cu(Aβ)-Induced Production of Reactive Oxygen Species: [3N1S] Is the Right Donor Set.
Malikidogo KP; Drommi M; Atrián-Blasco E; Hormann J; Kulak N; Esmieu C; Hureau C
Chemistry; 2023 Mar; 29(14):e202203667. PubMed ID: 36606721
[TBL] [Abstract][Full Text] [Related]
17. Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity.
Tõugu V; Tiiman A; Palumaa P
Metallomics; 2011 Mar; 3(3):250-61. PubMed ID: 21359283
[TBL] [Abstract][Full Text] [Related]
18. RTHLVFFARK-NH
Meng J; Zhang H; Dong X; Liu F; Sun Y
J Inorg Biochem; 2018 Apr; 181():56-64. PubMed ID: 29407908
[TBL] [Abstract][Full Text] [Related]
19. Hybrid Bis-Histidine Phenanthroline-Based Ligands to Lessen Aβ-Bound Cu ROS Production: An Illustration of Cu(I) Significance.
Drommi M; Rulmont C; Esmieu C; Hureau C
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946712
[TBL] [Abstract][Full Text] [Related]
20. Abeta-mediated ROS production by Cu ions: structural insights, mechanisms and relevance to Alzheimer's disease.
Hureau C; Faller P
Biochimie; 2009 Oct; 91(10):1212-7. PubMed ID: 19332103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]